FCMI

Foresite Capital Management III Portfolio holdings

AUM $37.9M
This Quarter Return
+1.45%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$453M
AUM Growth
+$453M
Cap. Flow
+$7.1M
Cap. Flow %
1.57%
Top 10 Hldgs %
80.58%
Holding
24
New
2
Increased
2
Reduced
9
Closed
–

Top Buys

1
REPL icon
Replimune Group
REPL
$12.6M
2
PACB icon
Pacific Biosciences
PACB
$6.14M
3
IMMU
Immunomedics Inc
IMMU
$3.12M
4
BDSI
BioDelivery Sciences International, Inc.
BDSI
$1.71M

Top Sells

1
SLDB icon
Solid Biosciences
SLDB
$4.72M
2
BPMC
Blueprint Medicines
BPMC
$3.9M
3
AKAO
Achaogen, Inc.
AKAO
$2M
4
XLRN
Acceleron Pharma Inc.
XLRN
$1.6M
5
AIMT
Aimmune Therapeutics, Inc.
AIMT
$1.36M

Sector Composition

1 Healthcare 57.52%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AERI
1
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$105M 23.2% 1,708,046 – –
IMMU
2
DELISTED
Immunomedics Inc
IMMU
$56.1M 12.37% 2,691,729 +150,000 +6% +$3.12M
ALDR
3
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$49M 10.81% 2,942,130 – –
RCUS icon
4
Arcus Biosciences
RCUS
$1.13B
$48M 10.6% 3,445,461 – –
MYOK
5
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$24.3M 5.36% 372,300 -20,489 -5% -$1.34M
AIMT
6
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$21.9M 4.82% 801,240 -49,973 -6% -$1.36M
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
$17.3M 3.82% 1,562,040 – –
BPMC
8
DELISTED
Blueprint Medicines
BPMC
$15.6M 3.44% 200,000 -50,000 -20% -$3.9M
XLRN
9
DELISTED
Acceleron Pharma Inc.
XLRN
$14.4M 3.17% 250,863 -27,890 -10% -$1.6M
ASND icon
10
Ascendis Pharma
ASND
$11.8B
$13.6M 3% 191,588 – –
REPL icon
11
Replimune Group
REPL
$422M
$12.6M 2.77% +779,656 New +$12.6M
BOLD
12
DELISTED
Audentes Therapeutics, Inc
BOLD
$12.5M 2.75% 315,331 – –
SLDB icon
13
Solid Biosciences
SLDB
$427M
$11.2M 2.48% 237,884 -100,000 -30% -$4.72M
EPZM
14
DELISTED
Epizyme, Inc
EPZM
$9.73M 2.15% 917,715 -22,970 -2% -$243K
AKAO
15
DELISTED
Achaogen, Inc.
AKAO
$9.47M 2.09% 2,374,418 -500,000 -17% -$2M
VRNA
16
Verona Pharma
VRNA
$9.16B
$6.27M 1.38% 500,883 -1,942 -0.4% -$24.3K
PACB icon
17
Pacific Biosciences
PACB
$393M
$6.14M 1.35% +1,135,000 New +$6.14M
ACRS icon
18
Aclaris Therapeutics
ACRS
$209M
$4.54M 1% 312,368 – –
SGMO icon
19
Sangamo Therapeutics
SGMO
$157M
$4.5M 0.99% 265,605 – –
BHVN
20
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$3.97M 0.88% 105,706 – –
WVE icon
21
Wave Life Sciences
WVE
$1.53B
$2.5M 0.55% 50,000 -25,000 -33% -$1.25M
FBRX icon
22
Forte Biosciences
FBRX
$137M
$2.32M 0.51% 148,552 – –
BDSI
23
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.76M 0.39% 629,656 +610,156 +3,129% +$1.71M
ARDX icon
24
Ardelyx
ARDX
$1.53B
$567K 0.13% 130,304 – –